Related Experiment Video
Updated: Oct 5, 2025

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
Cysteine Peptidase Cathepsin X as a Therapeutic Target for Simultaneous TLR3/4-mediated Microglia Activation
Anja Pišlar1, Biljana Božić Nedeljković2, Mina Perić2
1Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000, Ljubljana, Slovenia. anja.pislar@ffa.uni-lj.si.
Abstract:
Microglia are resident macrophages in the central nervous system that are involved in immune responses driven by Toll-like receptors (TLRs). Microglia-mediated inflammation can lead to central nervous system disorders, and more than one TLR might be involved in these pathological processes. The cysteine peptidase cathepsin X has been recognized as a pathogenic factor for inflammation-induced neurodegeneration. Here, we hypothesized that simultaneous TLR3 and TLR4 activation induces synergized microglia responses and that these phenotype changes affect cathepsin X expression and activity. Murine microglia BV2 cells and primary murine microglia were exposed to the TLR3 ligand polyinosinic-polycytidylic acid (poly(I:C)) and the TLR4 ligand lipopolysaccharide (LPS), individually and simultaneously. TLR3 and TLR4 co-activation resulted in increased inflammatory responses compared to individual TLR activation, where poly(I:C) and LPS induced distinct patterns of proinflammatory factors together with different patterns of cathepsin X expression and activity. TLR co-activation decreased intracellular cathepsin X activity and increased cathepsin X localization at the plasma membrane with concomitant increased extracellular cathepsin X protein levels and activity. Inhibition of cathepsin X in BV2 cells by AMS36, cathepsin X inhibitor, significantly reduced the poly(I:C)- and LPS-induced production of proinflammatory cytokines as well as apoptosis. Additionally, inhibiting the TLR3 and TLR4 common signaling pathway, PI3K, with LY294002 reduced the inflammatory responses of the poly(I:C)- and LPS-activated microglia and recovered cathepsin X activity. We here provide evidence that microglial cathepsin X strengthens microglia activation and leads to subsequent inflammation-induced neurodegeneration. As such, cathepsin X represents a therapeutic target for treating neurodegenerative diseases related to excess inflammation.
Insights
Simultaneous Toll-like receptor 3 and 4 activation in microglia boosts inflammation and neurodegeneration. Cathepsin X inhibition reduces these effects, highlighting its therapeutic potential for inflammatory neurodegenerative diseases.
Area of Science:
- Neuroimmunology
- Cellular and Molecular Neuroscience
Background:
- Microglia, the central nervous system's immune cells, are activated by Toll-like receptors (TLRs).
- Dysregulated microglia-mediated inflammation is implicated in neurodegenerative disorders.
- The cysteine peptidase cathepsin X is a known factor in inflammation-driven neurodegeneration.
Purpose of the Study:
- To investigate the synergistic effects of simultaneous TLR3 and TLR4 activation on microglia.
- To determine how this co-activation influences cathepsin X expression and activity.
- To explore cathepsin X as a potential therapeutic target in neuroinflammation.
Main Methods:
- Murine microglia (BV2 cells and primary cultures) were stimulated with TLR3 ligand poly(I:C) and TLR4 ligand LPS, individually and together.
- Analyzed inflammatory factor production, cathepsin X activity and localization.
- Utilized cathepsin X inhibitor (AMS36) and PI3K inhibitor (LY294002) to assess signaling pathways and therapeutic potential.
Main Results:
- TLR3 and TLR4 co-activation led to amplified inflammatory responses compared to single TLR activation.
- Co-activation altered cathepsin X activity and localization, increasing extracellular levels.
- Inhibiting cathepsin X or the PI3K pathway significantly reduced inflammatory cytokine production, apoptosis, and microglia activation.
Conclusions:
- Microglial cathepsin X activity is enhanced by combined TLR3/TLR4 stimulation, contributing to neuroinflammation.
- Cathepsin X plays a crucial role in amplifying microglia activation and subsequent neurodegeneration.
- Targeting cathepsin X offers a promising therapeutic strategy for neurodegenerative diseases driven by inflammation.

